All

FDA: Two Monoclonal Antibody Treatments Ineffective Against Omicron Variant

The FDA has removed two monoclonal antibody therapies from its list of emergency authorized COVID-19 treatments due to their ineffectiveness against the Omicron variant.

All

Cytokine Levels Could Predict Asthma Patients’ Response to Benralizumab

Levels of inflammatory cytokines in patients with severe asthma may predict responses to the monoclonal antibody benralizumab, a study in the Journal of Asthma suggests.

All

FDA Authorizes Symbiotica COVID-19 Self-Collected Antibody Test

The US FDA has issued an EUA for the Symbiotica COVID-19 Self-Collected Antibody Test System, the first antibody test authorized for use with home collected dried blood spot samples.

SARS-CoV-2 Antibody Test Helps Select Donor Blood Samples for Therapeutic Use

by RT Staff | Jan 14, 2021 | Clinical Trials, Testing | 0

A new COVID-19 antibody assay was able to detect IgG and IgM antibodies to determine viable donor samples for therapeutic use and clinical trials.

Clinical Trials Testing Two Monoclonal Antibodies for COVID-19

by RT Staff | Jan 13, 2021 | Clinical Trials, Other Infections, US Pharmaceuticals | 0

A Phase 2/3 clinical trial has begun to evaluate a combination investigational monoclonal antibody therapy used for COVID-19.

FDA Authorizes Regeneron’s Monoclonal Antibody Treatment for COVID-19

by RT Staff | Nov 23, 2020 | FDA Approvals, Other Infections, US Pharmaceuticals | 0

The FDA issued an emergency use authorization for Regeneron’s casirivimab and imdevimab to be administered together for the treatment of mild to moderate COVID-19 in patients 12 and older.

‘Breakthrough Finding’ Reveals Why Certain COVID Patients Die

by Lisa Spear | Nov 13, 2020 | Infectious Diseases | 2

Scientists have found that some people have antibodies against parts of their own immune system, allowing viruses to multiply rapidly.

FDA Authorizes Bamlanivimab for Treatment of COVID-19

by RT Staff | Nov 9, 2020 | FDA Approvals, Other Infections, US Pharmaceuticals | 0

The monoclonal antibody bamlanivimab reduced COVID-19-related hospitalization or ER visits in patients at high risk for disease progression within 28 days after treatment.

Coronavirus Immunity May Only Last 6 Months Post-infection

by RT Staff | Jun 19, 2020 | Other Infections | 0

Researchers at the University of Amsterdam conducted a study of human coronaviruses and found that post-infection immunity was not lasting, with reinfections at 12 months and as early as six months later.

Human Antibodies Produced from Cows 4-times More Potent against SARS-CoV-2

by RT Staff | Jun 10, 2020 | Other Infections, US Pharmaceuticals | 0

SAB-185, an investigational human polyclonal antibody derived from genetically-engineered cattle, reportedly neutralized SARS-CoV-2 four-times greater than convalescent plasma from humans.

A Plant-based System for the Production of Allergens for Immunotherapy

by RT Staff | May 11, 2020 | Allergies | 0

While allergen immunotherapy provides long-lasting therapeutic relief to people suffering from environmental allergies, the therapy can last several years and requires large amounts of allergen. Now, researchers from the University of Tsukuba developed a new solution.

Tag: antibodies

All

FDA: Two Monoclonal Antibody Treatments Ineffective Against Omicron Variant

FDA Authorizes AstraZeneca’s Long-Acting Monoclonal Antibodies

Regen-Cov Protects Against COVID-19 for up to Eight Months

Breast Milk May Prevent Allergies in Children of Traditional Farming Communities

AstraZeneca Requests Emergency Use for COVID-19 Antibody

WHO Recommends Regen-COV for COVID-19 Patients at High Risk of Hospital Admission

AstraZeneca Monoclonal Antibody Effective as Preventative Therapy

Antibody Protects Against Variants

All

Cytokine Levels Could Predict Asthma Patients’ Response to Benralizumab

Antibodies in Lungs Can Prevent Severe Respiratory Infections

FDA Authorizes Monoclonal Antibody Actemra for Hospitalized COVID-19 Patients

Regen-Cov Reduced COVID-19 Hospital Mortality by 20% in Seronegative Patients

FDA Okays Lower Dose of Regeneron Monoclonal Antibody Cocktail

FDA Revokes EUA for Monoclonal Antibody Bamlanivimab

Regeneron Monoclonal Antibodies Reduced COVID-19 Transmission Risk by 81%

All

FDA Authorizes Symbiotica COVID-19 Self-Collected Antibody Test

FDA to Review Expanded Application of Dupixent for Childhood Asthma

Monoclonal Antibodies Effective against MERS Coronavirus in First Human Trial

Low Reinfection Risk for People with SARS-CoV-2 Antibodies

FDA Authorizes Monoclonal Antibodies for COVID-19

Mothers Pass SARS-CoV-2 Antibodies to Newborns

COVID-19 Antibodies Protect for at least Six Months

SARS-CoV-2 Antibody Test Helps Select Donor Blood Samples for Therapeutic Use

Clinical Trials Testing Two Monoclonal Antibodies for COVID-19

FDA Authorizes Regeneron’s Monoclonal Antibody Treatment for COVID-19

‘Breakthrough Finding’ Reveals Why Certain COVID Patients Die

FDA Authorizes Bamlanivimab for Treatment of COVID-19

Coronavirus Immunity May Only Last 6 Months Post-infection

Human Antibodies Produced from Cows 4-times More Potent against SARS-CoV-2

A Plant-based System for the Production of Allergens for Immunotherapy

QuestDirect COVID-19 Antibody Test Available to Consumers

New High-speed COVID-19 Antibody Test Launched

Abbott COVID-19 Antibody Tests Begin Shipping

FDA Expanding Access to Blood-related Therapies for COVID-19